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Voxel-based analysis unveils 
regional dose differences 
associated with radiation-induced 
morbidity in head and neck cancer 
patients
Serena Monti  1, Giuseppe Palma2, Vittoria D’Avino2, Marianna Gerardi3, Giulia Marvaso3, Delia 
Ciardo3, Roberto Pacelli  4, Barbara A. Jereczek-Fossa3,5, Daniela Alterio3 & Laura Cella  2
The risk of radiation-induced toxicity in patients treated for head and neck (HN) cancer with radiation 
therapy (RT) is traditionally estimated by condensing the 3D dose distribution into a monodimensional 
cumulative dose-volume histogram which disregards information on dose localization. We 
hypothesized that a voxel-based approach would identify correlations between radiation-induced 
morbidity and local dose release, thus providing a new insight into spatial signature of radiation 
sensitivity in composite regions like the HN district. This methodology was applied to a cohort of HN 
cancer patients treated with RT at risk of radiation-induced acute dysphagia (RIAD). We implemented 
an inter-patient elastic image registration framework that proved robust enough to match even the 
most elusive HN structures and to provide accurate dose warping. A voxel-based statistical analysis was 
then performed to test regional dosimetric differences between patients with and without RIAD. We 
identified a significantly higher dose delivered to RIAD patients in two voxel clusters in correspondence 
of the cricopharyngeus muscle and cervical esophagus. Our study goes beyond the well-established 
organ-based philosophy exploring the relationship between radiation-induced morbidity and local dose 
differences in the HN region. This approach is generally applicable to different HN toxicity endpoints 
and is not specific to RIAD.
In radiation therapy (RT) treatment planning (TP), the dose-volume histogram (DVH), introduced in the 
late 1970s1, has proved to be a valuable tool for summarizing a three-dimensional (3D) dose distribution in a 
two-dimensional (2D) graph. For practical reasons, most biological models developed in RT to predict tumor 
control or normal tissue side effects start with the target or organ-at-risk (OAR) DVH, respectively, rather than 
with the complete radiation dose distribution. This implies that the structures of interest are considered homo-
geneous, and, therefore, any spatial dose distribution information and possible inhomogeneity in regional organ 
radiosensitivity are disregarded. Also, different definition of the OARs may influence the toxicity prediction2.
After nearly 40 years, we have reached the maturity and computational tools to exploit the information 
included in the full 3D dose distribution. Recently, 2D or 3D methods for dose distribution analysis (dose map-
ping), collectively referred to as voxel-based (VB) methods, have tried to evaluate local dose response patterns 
beyond the organ-based philosophy, and have been proposed as alternative approaches to the DVH for identify-
ing dose sensitive regions of normal tissue. These methods have been successfully applied to prostate and thoracic 
cancer patients3–8, but, to the best of our knowledge, no VB analysis has been performed on patients with tumors 
in the head and neck (HN) area.
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RT is one of the most effective modalities for the treatment of HN cancers. However, because of the complex 
shape of target volumes in close proximity to sensitive organs, it may be associated with acute and late radiation 
morbidities such as xerostomia, mucositis and dysphagia affecting the patient’s quality of life9. Many studies have 
investigated dose-volume predictors as well as spatial dose metrics in order to minimize those radiation induced 
side effects10–14. However, many of these studies might be limited by a large spectrum of issues ranging from the 
difficulty or inconsistency in the delineation of the related OARs to the use of a single summary measure from the 
DVH. In particular, the definition and contouring of swallowing-related normal tissues (i.e., the pharyngeal con-
strictor muscles, base of tongue, supraglottic larynx, soft palate, cricopharyngeal muscle and cervical esophagus) 
can be time consuming and prone to inter- and intra-operator variations13, 15.
At the same time, the use of the intensity-modulated RT (IMRT) for HN cancer treatment as a standard tech-
nique calls for an afterthought in the definition of dose and volume constraints for plan optimization in order to 
take full advantage of IMRT improved therapeutic ratio. This issue is even more important in light of the recent 
introduction in TP systems of automated engines designed to create an optimized plan with minimal user inter-
action. In HN region, in particular, they proved able to further improve the clinical quality of IMRT plans and 
OAR sparing16, 17.
Given this background, the current study was designed to apply a VB analysis in order to explore the correla-
tion between radiation induced acute dysphagia (RIAD) and local dose differences in a cohort of patients treated 
with RT for HN cancer. The VB approach relies on mapping all patient dose distributions into a single reference 
case anatomy, which serves as anchor for local dosimetric evaluations. Compared to other districts, the HN 
presents peculiar difficulties in the registration procedure, thus posing several challenges for the achievement of 
an accurate dose warping18, 19. We implemented an inter-patient elastic image registration (EIR) framework that 
proved robust enough to match even the most elusive structures involved in the investigated toxicity endpoint. 
Thereafter, a VB statistical analysis was performed to test dosimetric regional differences between patients with 
different outcomes. Finally, the application of the VB analysis in HN clinical TP optimization was verified.
Materials and Methods
Patient dataset. The patients analyzed in this study are part of a cohort of 100 subjects treated at the 
Department of Radiation Therapy of the European Institute of Oncology (Milano) for HN tumors, and prospec-
tively evaluated for radiation-induced acute dysphagia (RIAD). The study was part of a research regarding image 
guided RT for HN cancer approved by the Ethical Committee of the European Institute of Oncology (Notification 
n. 94/11). All patients gave written informed consent. All experimental protocols and procedures were performed 
in accordance with the guidelines of the European Institute of Oncology. All clinical imaging data were used in 
anonymized form. Applied selection criteria included:
•	 Curative RT for HN cancer associated or not with concurrent or induction chemotherapy;
•	 No prior surgery in HN region;
•	 No baseline mechanical dysphagia;
•	 No clinically relevant weight loss in the 3 months prior to RT;
•	 No requirement of enteral nutrition before RT.
A subset of 42 patients resulted eligible for the analysis. Twenty-three of these were treated with 3D conformal 
RT and the remaining 19 patients with IMRT. TP Computer Tomographic (CT) scans were acquired with an 
in-plane matrix of 512 × 512 and a slice thickness of 3 mm. Standard OARs, including oral cavity, larynx and eso-
phagus for HN, were contoured according to RTOG 061520. Median total prescribed RT dose was 70 Gy (range: 
[64, 70] Gy) in daily fractions of 2 Gy. All patients but one received induction (6/42) or concurrent chemotherapy 
(35/42).
Nine patients developed a severe RIAD (CTCAE v.4.0 grade ≥3). Patient, disease and treatment-related char-
acteristics were examined according to the development of RIAD by univariate statistical methods: categorical 
variables were tested by Pearson’s χ2-test or Fisher’s exact test when appropriate; continuous variables were tested 
by Mann-Whitney U-test. None of the considered clinical variables (gender, age, tumor stage and location, RT 
technique and chemotherapy) showed a significant correlation with RIAD. A detailed description of the patient 
and treatment characteristics has been reported elsewhere (submitted).
Data processing. Individual DICOM-RT plans (CT scans, dose maps, and contoured structures) were con-
verted into a Matlab (MathWorks, Natick, MA) object using the Computational Environment for Radiation ther-
apy Research software21.
The VB analysis, which entails
 1. inter-patient normalization consisting in the registration of CT and dose for each patient to a common 
spatial reference
 2. statistical analysis of regional dose differences between RIAD and non-RIAD patients’ groups,
was performed according to the scheme developed in Palma et al.5, as illustrated in the upper panel of Fig. 1.
Briefly, a masked planning CT of each patient was registered to a common coordinate system (CCS) via a 
log-diffeomorphic demons approach22, an EIR tool that guarantees the invertibility of the deformation field. The 
mask was given by the intersection of the patient’s body structure with the dilation (by a spherical structuring 
element of 30 mm radius) of the union of oral cavity, larynx and esophagus. The obtained deformation fields were 
used to map the dose of each patient into the CCS. The dose warping accuracy was evaluated by Dice23, modified 
Hausdorff distance (MHD)24 and dose-organ overlap (DOO)3 scores.
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Next, a preliminary significance analysis of the dose differences between groups was performed according to a 
non-parametric multiple comparison permutation test (104 permutations) by single maximum threshold, gener-
ally referred to as the normalized maximum dose difference, Tmax25. Having obtained the evidence that a statistical 
regional difference holds, a statistical mapping scheme for non-parametric multiple permutation inference on 
dose maps with threshold-free cluster enhancement (TFCE)26 was applied in order to highlight the clusters of 
voxels significantly associated with higher doses released in RIAD patients, within the region of the swallowing 
related structures (superior, middle and inferior pharyngeal constrictor muscles, cricopharyngeal muscle, cervi-
cal esophagus, base of tongue, supraglottic and glottic larynx15) segmented in the CCS.
A set of subregions {Sp} was thus defined as the family of the sublevel sets of the significance map in corre-
spondence of the TFCE significance level p. A Receiver Operating Characteristic- (ROC) based test was per-
formed on the mean doses {Dm,i|i = 1, …, 42} extracted from S0.05. Furthermore, the significance (pU) of the mean 
dose differences on Sp between RIAD and non-RIAD patients was evaluated by a Mann-Whitney U test and 
plotted as function of p.
Treatment Planning application. In order to demonstrate the practical relevance of the above analysis, a 
new IMRT plan (Plan1) for an oropharyngeal cancer patient (not included within the analyzed cohort) was gen-
erated according to Merlotti et al.27 for dose prescription, OARs dose-volume objectives and plan optimization. 
Three dose levels were prescribed to planning target volumes (PTVs): 70 Gy (2 Gy/die) for macroscopic disease 
(PTV1), 63 Gy (1.8 Gy/die) for high risk areas (PTV2), and 58.1 Gy (1.66 Gy/die) for low risk areas (PTV3).
A second plan (Plan2) was generated as a re-optimization of Plan1 by using the S0.05 structure as an avoidance 
region. For this purpose, the S0.05 region was warped as a new structure into the patient DICOM-RT plan accord-
ing to the deformation field that maps the CCS into the considered planning CT reference, estimated as before via 
log diffeomorphic demons. For the S0.05 structure we imposed the constraint that the corresponding mean dose 
(Dmean,S0.05) would not exceed the first percentile on RIAD patients (lower panel of Fig. 1). In this regard, since 
the number of RIAD patients is relatively low (in particular, less than 100), the first percentile was estimated as
| ∈ + | ∈ .·D i RIAD D i RIADmean({ }) stddev({ }) probit 0 01 (1)m i m i, ,
provided that the Kolmogorov-Smirnov test on | ∈D i RIAD{ }m i,  indicates that Gaussianity held.
Figure 1. Schematic flowchart of the voxel-based (VB) analysis (upper panel) and of its treatment planning 
(TP) application (lower panel) in head and neck (HN) cancer patients. Planning CTs are registered to the 
common coordinate system (CCS) by an elastic image registration (EIR) tool. The obtained deformation fields 
are used to warp the dose maps into the CCS. A statistical mapping scheme (TFCE) is applied to extract the 
clusters of voxels (S0.05) significantly associated with higher doses released in patients developing the radiation-
induced toxicity. For any new HN patient (case patient), the S0.05 region is warped as a new avoidance structure 
into the DICOM-RT object according to the deformation field that maps the CCS into the considered planning 
CT, and the corresponding mean dose (Dmean,S0.05) is used as planning constraint.
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Both plans were implemented using Volumetric Modulated Arc Therapy (VMAT) technique with two 
360°-arcs and nominal energy of 6MV. Plans were optimized by the automatic optimization module integrated in 
the TP system Pinnacle 9.10 (Philips Radiation Oncology Systems, Fitchburg, WI).
Data availability. The data analyzed in the present study are available at http://www.ibb.cnr.
it/?command=viewcms&and2=80&id=187.
Results
The registration process resulted in a geometrically robust and accurate dose warping, as confirmed by visual 
inspection on CT images (Fig. 2). Indeed, the voxelwise average of the patients’ CTs resulted much sharper after 
EIR, compared to the blurred appearance of the mean original CT. Moreover, the comparison of medians and 
ranges of Dice, MHD and DOO scores, computed before and after EIR on the whole patient dataset, showed a 
consistent significant improvement of inter-patient match accuracy (Table 1).
A significantly higher dose was delivered to RIAD patients, given a p = 0.038 value of the Tmax statistic. The 
S0.05 overall volume of 5.1 cm3 was located in two voxel-clusters in correspondence of the cricopharyngeus muscle 
and cervical esophagus (Figs 3 and 4). The area under the ROC curve (AUC) from the mean dose on S0.05 (Dm,i) 
resulted to be 0.81 (95% CI: [0.67, 0.95]). On RIAD patients, Dm,i ranged from 38 Gy to 58 Gy (median = 48 Gy) 
while on non-RIAD patients, Dm,i ranged from 10 Gy to 57 Gy (median = 33 Gy); at a Mann-Whitney U test the 
two distributions were significantly different (p = 0.003). Interestingly, the significance pU of the mean dose dif-
ferences between RIAD and non-RIAD patients within Sp subregions showed a global maximum (i.e. pU attains a 
minimum) roughly in correspondence of p = 0.05 (Fig. 5).
The p-value computed according to Kolmogorov-Smirnov test on | ∈D i RIAD{ }m i,  was 0.99, thus confirming 
that mean dose values in RIAD patients followed a Gaussian distribution. The first percentile of the distribution 
was thus estimated by equation (1) to be equal to 30.5 Gy.
The introduction of the S0.05 structure in Plan2 and the additional requirement in the optimization procedure 
that Dmean,S0.05 does not exceed 30.5 Gy led to a large sparing of the S0.05 (Dmean,S0.05: 30.4 Gy on Plan2 vs. 39.1 Gy on 
Plan1) at the cost of a negligible loss in the PTVs compared to Plan1 without jeopardizing the attainment of OAR 
objectives (Fig. 6).
Discussion
We established a comprehensive pipeline for the application of a VB approach to explore and to exploit the rela-
tionship between local dose release and radiation induced morbidity (Fig. 1). In particular, we implemented a 
procedure to assess local dose differences potentially associated to the development of RIAD. The developed tool 
was applied to a cohort of HN cancer patients treated with definitive RT and the identified significant subregion 
was subsequently used for TP optimization purpose in a representative patient.
Figure 2. Elastic image registration (EIR) results. Average of the patient population computed tomographic 
scans (a) before EIR and (b) after EIR, compared to (c) the corresponding reference patient’s scan.
Dice MHD (mm) DOO
pre post pre post pre post
Median 0.67 0.80 2.31 1.22 0.51 0.66
Range [0.03,0.83] [0.59,0.82] [0.53,24.13] [0.78,4.46] [0.02,0.68] [0.46,0.76]
p-value§ <10−5 <10−4 <10−6
Table 1. Registration scores for pre- and post-elastic image registration. Abbreviations: MHD, Modified 
Housdorff Distance; DOO, Dose-Organ Overlap. §p-values express the significance of the interpatient match 
improvement at Wilcoxon signed rank test.
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The technological RT developments, such as IMRT, have contributed to improve local tumor control in HN 
cancer patients, but also to reduce normal tissue doses, thus preventing radiation-induced side effects. Radiation 
induced toxicities in HN structures remain however the major dose-limiting factors and many survivors must 
cope with long-term effects of radiation treatments negatively impacting their quality of life. Besides radiation 
induced xerostomia, the swallowing dysfunction (i.e. dysphagia) is becoming one of the most relevant side effects 
of HN RT, more frequently observed in association with concomitant chemotherapy12, 13. Numbers of stud-
ies identified the DVH-parameters associated with both acute and late dysphagia in curative HN RT11–14, 28–30. 
Interestingly, acute dysphagia was a strong prognostic factor for late dysphagia31. However, most of those studies 
applied an organ-based approach that relies on identifying the multiple muscles and structures involved in the 
swallowing dysfunction, thus leading to a huge amount of dosimetric parameters and to the inherent well-known 
overfitting issue11, 13. In addition, the tiny and elusive swallowing related OARs exhibit a poor contrast on plan-
ning CTs (e.g. the cricopharyngeus and the three levels of pharyngeal constrictor muscles), hence posing concrete 
risks of structure misclassification. Indeed, the studies available in literature reported heterogeneous results con-
cerning the dose parameters predictive for late or acute dysphagia.
It is our belief that a possible solution to this conundrum is represented by a reversed, i.e. holistic, approach to the 
radiation-induced toxicity analysis. Instead of splitting further and further the organs into their substructures, the 
VB approach allows for a blind identification of the involved regions, irrespective of their anatomical classification.
Figure 3. Dose distribution differences. Sagittal view of: mean dose map (Gy) for patients (a) who experienced 
radiation-induced acute dysphagia and (b) who did not; (c) corresponding dose difference map; (d) subregions 
showing a statistically significant dose difference between groups (p < 0.05) according to TFCE permutation test 
(the color map represents -Log p).
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VB analyses have long been exploited in several neuroimaging frameworks, and the underlying philosophy 
has been recently introduced in the RT toxicity studies. The correlation between regional dose deposition and a 
toxicity outcome has been explored for a few organs, such as bladder, rectum and lungs3–8.
One of the major issues of the VB approach consists in the massive multiple comparison problem, which 
hinders a straightforward application of standard statistical tests, such as parametric (t) or non-parametric 
(Mann-Whitney) hypothesis tests. Solutions are available from the neuroimaging literature32; in this respect, we 
here adopted the non-parametric permutation inference coupled to the TFCE method26, which is particularly 
effective to enhance areas of signal that exhibit some spatial contiguity without relying on hard-threshold-based 
clustering.
The other central issue of the VB analysis concerns the inter-patient registration strategy adopted to anchor all 
the dose distributions to a common anatomical reference, which greatly impacts on the dose warping accuracy. 
In this study we implemented a multi-resolution version of the log-diffeomorphic demons approach22 which 
emerged as a highly performing scheme in the HN district according to Rigaud et al.18, 19. Indeed, the visual 
inspection of Fig. 2 as well as the Dice and MHD scores, reported in Table 1, indicates that the registration process 
was geometrically robust. Similarly, the DOO index shows that the method is accurate in dose warping.
Figure 4. Volume rendering of head and neck structures in the common coordinate system: (a) 3D body 
rendering of the reference patient along with the three structures (yellow) used to derive the registration mask 
(oral cavity, larynx and esophagus); (b) 3D rendering of the superior (light green), middle (cyan) and inferior 
(blue) pharyngeal constrictor muscles, the cricopharyngeus muscle (forest green) and the cervical esophagus 
(violet), along with the S0.05 structure (red), superimposed on the Digital Reconstructed Radiograph.
Figure 5. Discriminating power of mean dose in Sp subregions. Significance (pU), as evaluated by a Mann-
Whitney U test, of the mean dose differences on Sp between patients who developed toxicity and who did not.
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The joint application of registration process and statistical mapping led to the identification of a regional 
dose-RIAD relationship. Interestingly, the highlighted statistically significant subregion S0.05 is located in cor-
respondence of the cricopharyngeus muscle and cervical esophagus (Figs 3d and 4b), with a median dose of 
48 Gy in RIAD patients compared to the median dose of 33 Gy released to non-RIAD patients. The ROC analysis 
revealed a good prediction performance (AUC = 0.8) of the mean dose extracted from the subregion S0.05. Of 
note, Otter et al.13 found that mean dose to inferior pharyngeal constrictor muscles, immediately above the upper 
cluster in S0.05, is correlated with grade 3 acute dysphagia. Differently, the dose to the 2% of the superior pharyn-
geal constrictor was found to be a dosimetric predictor for the same endpoint by De Ruyck et al.12.
The evidence of a correlation between the dose delivered in a specific region of the swallowing-involved organs 
and the RIAD onset can be exploited to construct an avoidance criterion in the planning optimization strategy. 
The findings obtained by the statistical mapping analysis indeed allowed for an optimization of the TP procedure 
in a HN cancer patient external to the analyzed cohort. Furthermore, we demonstrated the practical feasibility of 
a S0.05 sparing plan (Plan2) within an IMRT framework (Fig. 6). In particular, the auto-planning engine coupled 
with the VMAT technique was applied to an oropharyngeal cancer patient with and without the S0.05 mean dose 
constraint. By adding the Dmean,S0.05 <30.5 Gy to the standard OAR optimization goals for the HN cancer IMRT 
and with only one single optimization cycle, we succeeded to sharply decrease the mean dose to the S0.05 structure 
and even to improve the sparing of all the OARs involved as it can be observed in Fig. 6c.
Remarkably, the presented results were obtained thanks to the heterogeneity of dose distribution within 
the considered cohort. Should the doses to the subregion S0.05 be lowered by a dedicated TP scheme, it may be 
expected that the incidence and severity of RIAD would be accordingly reduced, thus allowing the proposed 
method to provide knowledge on milder grade of radiation induced toxicities.
In conclusion, the VB method applied to HN tumor patients treated with RT successfully allowed to identify 
HN regions correlated with radiation-induced morbidity and, as such, it might be included in the IMRT opti-
mization strategy. Overall, the proposed approach may provide new insights into spatial signature of radiation 
sensitivity in a highly composite region such as the HN district. The practical relevance of the VB analysis in HN 
clinical TP optimization was also demonstrated.
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